Hepatitis C, Chronic

"Hepatitis C, Chronic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

INFLAMMATION of the LIVER in humans that is caused by HEPATITIS C VIRUS lasting six months or more. Chronic hepatitis C can lead to LIVER CIRRHOSIS.

Descriptor ID	D019698
MeSH Number(s)	C02.440.440.120 C02.782.350.350.120 C06.552.380.350.120 C06.552.380.705.440.120
Concept/Terms	Hepatitis C, Chronic Hepatitis C, Chronic Chronic Hepatitis C

Below are MeSH descriptors whose meaning is more general than "Hepatitis C, Chronic".

Diseases [C]
Virus Diseases [C02]
Hepatitis, Viral, Human [C02.440]
Hepatitis C [C02.440.440]
Hepatitis C, Chronic [C02.440.440.120]
RNA Virus Infections [C02.782]
Flaviviridae Infections [C02.782.350]
Hepatitis C [C02.782.350.350]
Hepatitis C, Chronic [C02.782.350.350.120]
Digestive System Diseases [C06]
Liver Diseases [C06.552]
Hepatitis [C06.552.380]
Hepatitis, Chronic [C06.552.380.350]
Hepatitis C, Chronic [C06.552.380.350.120]
Hepatitis, Viral, Human [C06.552.380.705]
Hepatitis C [C06.552.380.705.440]
Hepatitis C, Chronic [C06.552.380.705.440.120]

Below are MeSH descriptors whose meaning is related to "Hepatitis C, Chronic".

Below are MeSH descriptors whose meaning is more specific than "Hepatitis C, Chronic".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Hepatitis C, Chronic" by people in this website by year, and whether "Hepatitis C, Chronic" was a major or minor topic of these publications.

Bar chart showing 69 publications over 21 distinct years, with a maximum of 9 publications in 2012 and 2013

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2002	1	0	1
2003	1	0	1
2004	0	1	1
2005	2	1	3
2006	5	0	5
2007	5	1	6
2008	2	0	2
2009	1	0	1
2010	2	0	2
2011	2	0	2
2012	8	1	9
2013	9	0	9
2014	3	0	3
2015	5	0	5
2016	3	0	3
2017	4	0	4
2018	4	0	4
2020	2	0	2
2021	1	0	1
2022	3	0	3
2023	2	0	2

Below are the most recent publications written about "Hepatitis C, Chronic" by people in Profiles.

Karasz A, Merchant K, Arnsten J, Feinberg J, Kim AY, Lum PJ, McKee MD, Mehta SH, Meissner P, Norton BL, Page K, Pericot-Valverde I, Singh R, Stein E, Taylor LE, Tsui JI, Wagner K, Litwin A. A Video-Observed Treatment Strategy to Improve Adherence to Treatment Among Persons Who Inject Drugs Infected With Hepatitis C Virus: Qualitative Study of Stakeholder Perceptions and Experiences. J Med Internet Res. 2023 06 02; 25:e38176.

View in: PubMed
Karasz A, Merchant K, Singh R, Thomas A, Borsuk C, McKee D, Duryea P, Kim AY, Mehta S, Norton BL, Page K, Pericot-Valverde I, Sedillo S, Stein ES, Taylor LE, Tsui J, Litwin A. The experience of re-infection among people who inject drugs successfully treated for hepatitis C. J Subst Use Addict Treat. 2023 03; 146:208937.

View in: PubMed
Mondal S, Chen Y, Lockbaum GJ, Sen S, Chaudhuri S, Reyes AC, Lee JM, Kaur AN, Sultana N, Cameron MD, Shaffer SA, Schiffer CA, Fitzgerald KA, Thompson PR. Dual Inhibitors of Main Protease (MPro) and Cathepsin L as Potent Antivirals against SARS-CoV2. J Am Chem Soc. 2022 11 23; 144(46):21035-21045.

View in: PubMed
Conti J, Dryden E, Fincke BG, Dunlap S, McInnes DK. Innovative Approaches to Engaging Homeless and Marginally Housed Patients in Care: a Case Study of Hepatitis C. J Gen Intern Med. 2023 01; 38(1):156-164.

View in: PubMed
Clements KM, Kunte PS, Clark MA, Gurewich D, Greenwood BC, Sefton L, Pratt C, Person SD, Wessolossky MA. Uptake of hepatitis C virus treatment in a multi-state Medicaid population, 2013-2017. Health Serv Res. 2022 12; 57(6):1312-1320.

View in: PubMed
Turgeon MK, Shah SA, Delman AM, Tran BV, Agopian VG, Wedd JP, Magliocca JF, Kim A, Cameron A, Olyaei A, Orloff SL, Anderson MP, Kubal CA, Cannon RM, Locke JE, Simpson MA, Akoad ME, Wongjirad CP, Emamaullee J, Moro A, Aucejo F, Feizpour CA, Vagefi PA, Nguyen MH, Esquivel CO, Dhanireddy K, Subramanian V, Chavarriaga A, Kazimi MM, Anderson MS, Sonnenday CJ, Kim SC, Foley DP, Abdouljoud M, Salgia RJ, Moris D, Sudan DL, Ganesh SR, Humar A, Doyle M, Chapman WC, Maithel SK. Optimal Timing of Administration of Direct-acting Antivirals for Patients With Hepatitis C-associated Hepatocellular Carcinoma Undergoing Liver Transplantation. Ann Surg. 2021 10 01; 274(4):613-620.

View in: PubMed
Bailey DE, Zucker DM. Supportive Interventions During Treatment of Chronic Hepatitis C: A Review of the Literature. Gastroenterol Nurs. 2020 Sep/Oct; 43(5):E172-E183.

View in: PubMed
Owens DK, Davidson KW, Krist AH, Barry MJ, Cabana M, Caughey AB, Donahue K, Doubeni CA, Epling JW, Kubik M, Ogedegbe G, Pbert L, Silverstein M, Simon MA, Tseng CW, Wong JB. Screening for Hepatitis C Virus Infection in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement. JAMA. 2020 03 10; 323(10):970-975.

View in: PubMed
Kollar B, Rizzo NM, Borges TJ, Haug V, Abdulrazzak O, Kauke M, Safi AF, Lian CG, Marty FM, Rutherford AE, Mitchell RN, Murphy GF, Tullius SG, Riella LV, Pomahac B. Accelerated chronic skin changes without allograft vasculopathy: A 10-year outcome report after face transplantation. Surgery. 2020 06; 167(6):991-998.

View in: PubMed
Adejumo AC, Adegbala OM, Adejumo KL, Bukong TN. Reduced Incidence and Better Liver Disease Outcomes among Chronic HCV Infected Patients Who Consume Cannabis. Can J Gastroenterol Hepatol. 2018; 2018:9430953.

View in: PubMed

People

Explore

Similar Concepts

Top Journals